Dr. Frank M. Berger, Head of Analytics, Global Clinical Operations at Boehringer Ingelheim, will present “Case Study – Protocol Complexity” during the January 23, 2020 Study Quality Trailblazer meeting at 10AM EST.
Dr. Berger will cover the following topics:
- What is complexity?
- Trial complexity and protocol complexity
- Common beliefs around trial complexity
- Different perspectives
- How to measure trial /protocol complexity
- Call to action: Let’s collaborate!
MCC members can register for the January 23 meeting by visiting the Study Quality Trailblazer Work Group page on the MCC member website. Contact Lara Knitter, MCC Customer Service & Product Support for assistance.
Learn more about the Study Quality Trailblazer Best Practice Community.
Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.